Dr Ross O’Neill, Neuromod founder and CEO

Neuromod secures global regulatory approvals for Lenire tinnitus device

Dublin-based medical device company Neuromod Devices has secured critical regulatory approvals that will expand global access to its Lenire tinnitus treatment system. The company announced simultaneous approvals for Medical Device Single Audit Program (MDSAP) certification and EU Medical Device Regulation (MDR) compliance.

Siemens Healthineers Naeotom Alpha.Prime for radiation treatment

Siemens Healthineers launches photon-counting CT for radiotherapy

Siemens Healthineers has unveiled a photon-counting CT scanner specifically designed for radiation therapy planning, aiming to improve treatment accuracy for cancer patients through enhanced imaging capabilities.

Neusoft Medical Systems NeuViz P10 photon-counting CT

Neusoft Medical Systems launches photon-counting CT in China

Neusoft Medical Systems has announced that its NeuViz P10 photon-counting CT (PCCT) has received market approval from China’s National Medical Products Administration (NMPA). The system represents the first photon-counting CT approved in China and the world’s first wide-body system equipped with an 8-cm detector.

AI designed bacteriophage

Synthetic biology breakthrough: Scientists use AI to create viable bacteriophages from scratch

Researchers have successfully used genome language models to design complete, functional bacteriophage genomes, marking the first generative design of whole living organisms. The breakthrough demonstrates AI’s capacity to access novel evolutionary spaces and create phage cocktails that rapidly overcome bacterial resistance.

MEDICAL JAPAN 2025 TOKYO

MEDICAL JAPAN 2025 TOKYO to showcase new pavilions, collaborations, and innovations

Healthcare professionals, business leaders, and innovators from across Asia and beyond will converge at Makuhari Messe for MEDICAL JAPAN 2025 TOKYO to experience an immersive exhibition of medical, elderly care, pharmacy, and healthcare, with over 650 exhibitors and an anticipated 18,000 visitors from October 1 to 3, 2025.

sound waves

New research shows sound waves trigger cellular gene responses and suppress fat development

Researchers in Japan have demonstrated that acoustic waves in the audible frequency range can directly modulate gene expression in mammalian cells and significantly inhibit adipocyte differentiation. The study reveals a novel mechanotransduction pathway linking sound stimulation to cellular responses via focal adhesion signalling, opening potential applications in regenerative medicine and biotechnology.

hospital food

Strategic menu swaps for hospital food could prompt patients to choose healthier options

New research has shown hospital patients could reduce the carbon footprint and saturated fat content of their selected meals by up to almost a third through strategic reorganisation of weekly menus without removing any dishes, according to a University of Bristol study published in Philosophical Transactions of the Royal Society B.

GPT-5 logo

GPT-5 surpasses human doctors in medical diagnosis tests

Researchers at Emory University have demonstrated that GPT-5, the latest large language model from OpenAI, significantly outperforms human medical experts on standardised diagnostic reasoning tasks. The AI achieved remarkable accuracy rates exceeding 95% on medical licensing examinations whilst showing particular strength in integrating visual and textual clinical information.  

GE HealthCare unveils Vivid Pioneer ultrasound system

GE HealthCare launches premium AI-powered cardiovascular ultrasound

GE HealthCare has announced the launch of its most advanced cardiovascular ultrasound system, the Vivid Pioneer, featuring next-generation AI automation and enhanced imaging capabilities designed to transform cardiac diagnostic workflows. The ultra-premium system has received both CE Mark approval and U.S. FDA 510(k) clearance, positioning it for global deployment in cardiovascular care settings.

Newly engineered human brain organoids reveal myelin production and repair processes

Researchers have engineered sophisticated human brain organoids that faithfully model myelin production and repair processes. The groundbreaking model integrates immune cells called microglia, revealing their essential role in remyelination and providing a powerful new platform for testing potential multiple sclerosis therapies.